Literature DB >> 35679261

TLR7 Mediates Acute Respiratory Distress Syndrome in Sepsis by Sensing Extracellular miR-146a.

Huang Huang1, Jing Zhu1, Lili Gu1, Jiang Hu1, Xiujing Feng1, Weiliang Huang2, Sheng Wang1, Yang Yang1, Ping Cui1, Shao-Hsuan Lin1, Andrew Suen1, Briana K Shimada1, Brittney Williams1, Maureen A Kane2, Yunbo Ke1, Chen-Ou Zhang3, Anna A Birukova3, Konstantin G Birukov1,3, Wei Chao1, Lin Zou1.   

Abstract

TLR7 (Toll-like receptor 7), the sensor for single-stranded RNA, contributes to systemic inflammation and mortality in murine polymicrobial sepsis. Recent studies show that extracellular miR-146a-5p serves as a TLR7 ligand and plays an important role in regulating host innate immunity. However, the role of miR-146a-5p and TLR7 signaling in pulmonary inflammation, endothelial activation, and sepsis-associated acute respiratory distress syndrome remains unclear. Here, we show that intratracheal administration of exogenous miR-146a-5p in mice evokes lung inflammation, activates endothelium, and increases endothelial permeability via TLR7-dependent mechanisms. TLR7 deficiency attenuates pulmonary barrier dysfunction and reduces lung inflammatory response in a murine sepsis model. Moreover, the impact of miR-146a-5p-TLR7 signaling on endothelial activation appears to be a secondary effect because TLR7 is undetectable in the human pulmonary artery and microvascular endothelial cells (ECs), which show no response to direct miR-146a-5p treatment in vitro. Both conditioned media of miR-146a-5p-treated macrophages (Mϕ) and septic sera of wild-type mice induce a marked EC barrier disruption in vitro, whereas Mϕ conditioned media or septic sera of TLR7-/- mice do not exhibit such effect. Cytokine array and pathway enrichment analysis of the Mϕ conditioned media and septic sera identify TNFα (tumor necrosis factor α) as the main downstream effector of miR-146a-5p-TLR7 signaling responsible for the EC barrier dysfunction, which is further supported by neutralizing anti-TNFα antibody intervention. Together, these data demonstrate that TLR7 activation elicits pulmonary inflammation and endothelial barrier disruption by sensing extracellular miR-146a-5p and contributes to sepsis-associated acute respiratory distress syndrome.

Entities:  

Keywords:  Toll-like receptors; acute respiratory distress syndrome; innate immunity; microRNAs; sepsis

Mesh:

Substances:

Year:  2022        PMID: 35679261      PMCID: PMC9447138          DOI: 10.1165/rcmb.2021-0551OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   7.748


  50 in total

Review 1.  Endothelial barrier dysfunction in septic shock.

Authors:  S M Opal; T van der Poll
Journal:  J Intern Med       Date:  2015-03       Impact factor: 8.989

2.  Mapping of TLR5 and TLR7 in central and distal human airways and identification of reduced TLR expression in severe asthma.

Authors:  M M Shikhagaie; C K Andersson; M Mori; I Kortekaas Krohn; A Bergqvist; R Dahl; E Ekblad; H J Hoffmann; L Bjermer; J S Erjefält
Journal:  Clin Exp Allergy       Date:  2014-02       Impact factor: 5.018

Review 3.  Do monoclonal antibodies and anticytokines still have a future in infectious diseases?

Authors:  J Cohen; D Heumann; M P Glauser
Journal:  Am J Med       Date:  1995-12-29       Impact factor: 4.965

Review 4.  Acute Respiratory Distress Syndrome: Advances in Diagnosis and Treatment.

Authors:  Eddy Fan; Daniel Brodie; Arthur S Slutsky
Journal:  JAMA       Date:  2018-02-20       Impact factor: 56.272

5.  Extracellular RNA mediates endothelial-cell permeability via vascular endothelial growth factor.

Authors:  Silvia Fischer; Tibo Gerriets; Carina Wessels; Maureen Walberer; Sawa Kostin; Erwin Stolz; Kirila Zheleva; Andreas Hocke; Stefan Hippenstiel; Klaus T Preissner
Journal:  Blood       Date:  2007-06-18       Impact factor: 22.113

6.  Cardiac RNA induces inflammatory responses in cardiomyocytes and immune cells via Toll-like receptor 7 signaling.

Authors:  Yan Feng; Hongliang Chen; Jiayan Cai; Lin Zou; Dan Yan; Ganqiong Xu; Dan Li; Wei Chao
Journal:  J Biol Chem       Date:  2015-09-11       Impact factor: 5.157

7.  Pleiotropic effects of interleukin-6 in a "two-hit" murine model of acute respiratory distress syndrome.

Authors:  Julia L Goldman; Saad Sammani; Carrie Kempf; Laleh Saadat; Eleftheria Letsiou; Ting Wang; Liliana Moreno-Vinasco; Alicia N Rizzo; Jeffrey D Fortman; Joe G N Garcia
Journal:  Pulm Circ       Date:  2014-06       Impact factor: 3.017

8.  Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo.

Authors:  Fabrizio Orsenigo; Costanza Giampietro; Aldo Ferrari; Monica Corada; Ariane Galaup; Sara Sigismund; Giuseppe Ristagno; Luigi Maddaluno; Gou Young Koh; Davide Franco; Vartan Kurtcuoglu; Dimos Poulikakos; Peter Baluk; Donald McDonald; Maria Grazia Lampugnani; Elisabetta Dejana
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

9.  Nanoparticle delivery of microRNA-146a regulates mechanotransduction in lung macrophages and mitigates injury during mechanical ventilation.

Authors:  Christopher M Bobba; Qinqin Fei; Vasudha Shukla; Hyunwook Lee; Pragi Patel; Rachel K Putman; Carleen Spitzer; MuChun Tsai; Mark D Wewers; Robert J Lee; John W Christman; Megan N Ballinger; Samir N Ghadiali; Joshua A Englert
Journal:  Nat Commun       Date:  2021-01-12       Impact factor: 14.919

Review 10.  Integrating molecular pathogenesis and clinical translation in sepsis-induced acute respiratory distress syndrome.

Authors:  Joshua A Englert; Christopher Bobba; Rebecca M Baron
Journal:  JCI Insight       Date:  2019-01-24
View more
  2 in total

Review 1.  Modes of action and diagnostic value of miRNAs in sepsis.

Authors:  Nikolaos Antonakos; Charly Gilbert; Charlotte Théroude; Irene T Schrijver; Thierry Roger
Journal:  Front Immunol       Date:  2022-08-05       Impact factor: 8.786

2.  ExRNA Takes a Toll in Sepsis-associated Lung Injury.

Authors:  L K Metthew Lam; Nilam S Mangalmurti
Journal:  Am J Respir Cell Mol Biol       Date:  2022-09       Impact factor: 7.748

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.